You are using an older browser version. Please use a supported version for the best MSN experience.

FDA panel reviews Pfizer's COVID vaccine for kids

U.S. health advisers are deliberating whether kid-size doses of Pfizer's COVID-19 vaccine are safe and effective for 5- to 11-year-olds. Tuesday's meeting of the FDA panel is the first step toward expanding vaccinations to 28 million youngsters. (Oct. 26)
image beaconimage beaconimage beacon